Cerebrovascular disease and stroke are related to high risk of cognitive impairment. One of the main neuropsychological features in vascular cognitive impairment and vascular dementia is executive dysfunction. Definition of the essential subcomponents and concepts of executive function is important
โฆ LIBER โฆ
Assessment of Executive Function in Clinical Trials
โ Scribed by Ylikoski, Raija; Hnninen, Tuomo
- Book ID
- 118267968
- Publisher
- Cambridge University Press
- Year
- 2003
- Tongue
- English
- Weight
- 376 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1041-6102
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Assessment of Executive Function in Clin
โ
Ylikoski, Raija; Hnninen, Tuomo
๐
Article
๐
2003
๐
Cambridge University Press
๐
English
โ 376 KB
Assessing cognitive function in clinical
โ
Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 435 KB
Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (
ASSESSING COGNITIVE FUNCTION IN CLINICAL
โ
Jennifer H. Barnett; Trevor W. Robbins; Barbara J. Sahakian; Andrew D. Blackwell
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 80 KB
Assessing Executive Function in Preschoo
โ
Peter J. Anderson, Natalie Reidy
๐
Article
๐
2012
๐
Springer US
๐
English
โ 349 KB
Patient assessment in clinical trials
โ
Guy, William
๐
Article
๐
1982
๐
Elsevier Science
๐
English
โ 437 KB
Assessment of executive functions in sch
โ
L. Krabbendam; M.M.A. Derix; J. Jolles
๐
Article
๐
1998
๐
Elsevier Science
๐
English
โ 102 KB